NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
22.450 |
Evidence |
O
|
RELA |
RELA, NFKB3: Transcription factor p65 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
22.450 |
Evidence |
|
UTX |
UTX: Ubiquitously transcribed X chromosome tetratricopeptide repeat protein |
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
22.450 |
Evidence |
|
JUNB |
JUNB: Transcription factor jun-B |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
22.450 |
Evidence |
|
CHAF1B |
CHAF1B, CAF1A, CAF1P60, MPHOSPH7, MPP7: Chromatin assembly factor 1 subunit B |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
22.450 |
Evidence |
|
PRKAB2 |
PRKAB2: 5'-AMP-activated protein kinase subunit beta-2 |
PRKAG2 |
PRKAG2: 5'-AMP-activated protein kinase subunit gamma-2 |
22.430 |
Evidence |
|
JUNB |
JUNB: Transcription factor jun-B |
DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
22.430 |
Evidence |
|
MYB |
MYB: Myb proto-oncogene protein |
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
22.430 |
Evidence |
|
THY1 |
THY1: Thy-1 membrane glycoprotein precursor |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
22.430 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
IRS2 |
IRS2: Insulin receptor substrate 2 |
22.430 |
Evidence |
|
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
PLEKHA5 |
PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member |
22.430 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
22.430 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
22.430 |
Evidence |
O
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
22.430 |
Evidence |
|
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
22.430 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
22.430 |
Evidence |
O
|
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
22.430 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
22.430 |
Evidence |
|
CD4 |
CD4: T-cell surface glycoprotein CD4 precursor |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
22.430 |
Evidence |
|
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
22.430 |
Evidence |
|
CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
22.430 |
Evidence |
|
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
22.430 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
22.430 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
22.430 |
Evidence |
|
CD4 |
CD4: T-cell surface glycoprotein CD4 precursor |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
22.430 |
Evidence |
|